Longfei Mao

Longfei Mao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2024 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
XHXixi Hou
Xixi Hou
LMLongfei Mao
Longfei Mao
XZXuanwei Zhang
Xuanwei Zhang
XWXi Wang
Xi Wang
LWLan Wang
Lan Wang
JWJianji Wang
Jianji Wang

15 October 2024 in The Journal of Physiological Sciences
Verified
Journal Article
Open access
PDF file
MYMengli Yang
Mengli Yang
SLSanqiang Li
Sanqiang Li
RLRenli Luo
Renli Luo
YZYadi Zhao
Yadi Zhao
YSYue Sun
Yue Sun
LMLongfei Mao
Longfei Mao
The effect and molecular regulatory mechanism of A Disintegrin and Metalloproteinase 8 (ADAM8) were explored in alcoholic liver fibrosis (ALF). C57BL/6N male mice were randomly divided into control, alcohol, and ADAM8-sgRNA3 plasmid groups. The control group received control liquid diet, while the alcohol and ADAM8-sgRNA3 plasmid groups were given alcohol liquid feed diet combined with ethanol gavage treatment for 8 weeks to induce ALF modeling. In addition, the ADAM8-sgRNA3 plasmid group was injected with the effective ADAM8-sgRNA3 plasmid, while the alcohol and control group mice were injected with an equivalent amount of physiological saline. LX-2 human hepatic stellate cells were divided into control, alcohol, si-ADAM8-2, and si-ADAM8-NC groups and induced for 48 h for model establishment in vitro. Serological detection, pathological staining, Western blotting, qRT-PCR and CCK8 assay were performed for experiments. Compared with the alcohol group, ADAM8 mRNA, protein and, positive area rate, serological indicators, pathological changes, and the expression of liver fibrosis marker and MAPK signaling pathway-related factors in the ADAM8-sgRNA3 plasmid group significantly decreased in vivo. Compared with the alcohol group, ADAM8 mRNA and protein expression, cell viability, and the expression of liver fibrosis markers and MAPK signaling pathway-related factors (p-ERK1/2, PCNA, Bcl-2, p-c-Jun, TGFβ1, p–p38 MAPK and HSP27) reduced significantly in the si-ADAM8-2 group. Therefore, ADAM8 promotes ALF through the MAPK signaling pathway, a promising target for treating ALF.

1 December 2024 in Russian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
DYDong Yan
Dong Yan
XHXixi Hou
Xixi Hou
ZWZiyuan Wu
Ziyuan Wu
XWXinyan Wang
Xinyan Wang
XHXueqin Hao
Xueqin Hao
LMLongfei Mao
Longfei Mao
Dolutegravir, a potent HIV integrase inhibitor, is currently synthesized via routes that have several drawbacks, including low yields, high formation of by-products, and complexities of operations. In this study, we seek to tackle these challenges by developing a new synthesis route for dolutegravir. We designed a new synthesis route based on the existing one, utilizing low-cost starting materials to achieve a dolutegravir production purity of 99.6%. We thus overcome the limitations of the existing synthesis methods and improve the overall efficiency and cost-effectiveness of dolutegravir synthesis.